Lineage Cell Therapeutics
LCTX
#8221
Rank
โ‚ฌ0.14 B
Marketcap
0,78ย โ‚ฌ
Share price
1.22%
Change (1 day)
-35.11%
Change (1 year)

Lineage Cell Therapeutics (LCTX) - Total assets

Total assets on the balance sheet as of June 2024 : โ‚ฌ93.96 M

According to Lineage Cell Therapeutics 's latest financial reports the company's total assets are โ‚ฌ93.96 M. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Lineage Cell Therapeutics - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ91.38 M-20.73%
2022-12-31โ‚ฌ0.11 B-25.2%
2021-12-31โ‚ฌ0.15 B75.61%
2020-12-31โ‚ฌ87.76 M-21.65%
2019-12-31โ‚ฌ0.11 B26.05%
2018-12-31โ‚ฌ88.86 M-38.45%
2017-12-31โ‚ฌ0.14 B6.52%
2016-12-31โ‚ฌ0.13 B56.56%
2015-12-31โ‚ฌ86.57 M40.57%
2014-12-31โ‚ฌ61.58 M47.33%
2013-12-31โ‚ฌ41.8 M85.88%
2012-12-31โ‚ฌ22.48 M-36.27%
2011-12-31โ‚ฌ35.29 M-11.89%
2010-12-31โ‚ฌ40.05 M327.16%
2009-12-31โ‚ฌ9.37 M1165.88%
2008-12-31โ‚ฌ0.74 M517.62%
2007-12-31โ‚ฌ0.11 M-75.67%
2006-12-31โ‚ฌ0.49 M-70.19%
2005-12-31โ‚ฌ1.65 M47.41%
2004-12-31โ‚ฌ1.12 M31.79%
2003-12-31โ‚ฌ0.85 M-40.53%
2002-12-31โ‚ฌ1.43 M-34.89%
2001-12-31โ‚ฌ2.19 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ0.30 B 219.94%๐Ÿ‡บ๐Ÿ‡ธ USA